Spinal Cord Stimulation Efficacy Measures
Chronic Pain in the Trunk and Limbs
About this trial
This is an interventional treatment trial for Chronic Pain in the Trunk and Limbs focused on measuring Spinal cord stimulation, Spinal cord stimulation efficacy, Spinal cord stimulators, Stimulation frequencies, Stimulation pulse-widths, Varying settings
Eligibility Criteria
Inclusion Criteria: The patient must have SCS implanted for at least 2 months before study start date The patient must be at least 18 years old The patient must currently be receiving pain relief from SCS usage The patient must be willing to participate in a 9-week study The patient must have at least 20% of battery life remaining in his/her spinal cord stimulator The patient must be able to tolerate Vicodin-Extra Strength as well as Tylenol, but can also take their own pain medication if it is not one of the two mentioned Exclusion Criteria: The patient is pregnant or intends to become pregnant during the course of the study. The patient by report, and/or by physician assessment, exhibits any or all of the following, which might bias reporting of treatment outcome: A strong untreated dependency on prescription medication such as benzodiazepines and narcotic analgesics. A strong potential for secondary gain issues. A significant, untreated psychiatric comorbidity. The patient possesses a coexisting clinically relevant or disabling chronic pain problem not treated by SCS The patient has been diagnosed with unstable angina The patient receives a Karnofsky's performance score of <60
Sites / Locations
- The Brookdale University Hospital and Medical CenterRecruiting
- New York Neurosurgery & Neuroscience Associates, PLLCRecruiting